Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy: results from the SEARCH database

Study Type – Diagnosis (exploratory cohort)
 Level of Evidence 2b

[1]  M. Terris,et al.  Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database , 2009, Prostate Cancer and Prostatic Diseases.

[2]  T. Dorff,et al.  Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy , 2008, BJU international.

[3]  J. Mohler,et al.  Effect of perioperative blood transfusion on prostate cancer recurrence. , 2008, Urologic oncology.

[4]  M. Kattan,et al.  Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories. , 2008, The Journal of urology.

[5]  M. Kattan,et al.  Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. , 2008, European urology.

[6]  M. Terris,et al.  Race, biochemical disease recurrence, and prostate–specific antigen doubling time after radical prostatectomy , 2007, Cancer.

[7]  M. Kattan,et al.  The surgical learning curve for prostate cancer control after radical prostatectomy. , 2007, Journal of the National Cancer Institute.

[8]  P. Camparo,et al.  The expression of vascular endothelial growth factor is associated with the risk of cancer progression after radical prostatectomy , 2007, BJU international.

[9]  Y. Mohri,et al.  Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[10]  N. Masumori,et al.  Early and late complications of radical retropubic prostatectomy: experience in a single institution. , 2004, Japanese journal of clinical oncology.

[11]  J. Minei,et al.  Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. , 2002, The Journal of trauma.

[12]  P. Carroll,et al.  Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. , 2000, The Journal of urology.

[13]  H. Clark,et al.  Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta‐analysis of unconfounded studies , 1998, The British journal of surgery.

[14]  L. Goodnough,et al.  A standardized method for calculating blood loss , 1997, Transfusion.

[15]  J. Eickhoff,et al.  Peri-operative blood transfusion in relation to tumour recurrence and death after surgery for prostatic cancer. , 1991, British journal of urology.

[16]  D. Cranston,et al.  Effect of blood transfusion on survival after radiotherapy as treatment for carcinoma of the prostate. , 1991, Annals of the Royal College of Surgeons of England.

[17]  D. Kerridge,et al.  Blood transfusion and survival following surgery for prostatic carcinoma , 1990, The British journal of surgery.

[18]  N. Blumberg,et al.  Perioperative blood transfusions and prostate cancer recurrence and survival. , 1988, American journal of surgery.

[19]  P. Walsh,et al.  An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery. , 1979, The Journal of urology.

[20]  H. Foss.  THE CONTROL OF HEMORRHAGE FOLLOWING PROSTATECTOMY , 1923, Annals of surgery.

[21]  임재영,et al.  BMI(Body Mass Index)가 소득에 미치는 영향 , 2012 .

[22]  C. Kane,et al.  Effects of hospital procedure volume and resident training on clinical outcomes and resource use in radical retropubic prostatectomy surgery in the Department of Veterans Affairs. , 2008, The Journal of urology.